Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CSH1 deubiquitinates ZUP1 on proline. 2 / 2

| 2

➶

reach

"In addition, PL pro exhibits deubiquitinating (DUB) activity and antagonizes the induction of type-1 interferon (IFN)."

28112000

➶

reach

"Like its SARS-CoV counterpart, the MERS-CoV PL pro also has deubiquitinating (DUB) and deISGylating activities in vivo as well as in vitro (Yang et al., 2013; Mielech et al., 2014; Lei et al., 2014; Baez-Santos et al., 2014b) ."

27245450

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...